{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:31:25Z","timestamp":1788546685916,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.lanwpc.2024.101032","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T17:35:33Z","timestamp":1709055333000},"page":"101032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Varenicline solution nasal spray for dry eye disease in Chinese patients: a randomized phase 3 trial"],"prefix":"10.1016","volume":"45","author":[{"given":"Lei","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaozhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linnong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faming","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaopin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2397-2176","authenticated-orcid":false,"given":"Zhiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2649-8241","authenticated-orcid":false,"given":"Ying","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lanwpc.2024.101032_bib1","first-page":"418","volume":"56","year":"2020","journal-title":"Chin J Ophthalmol"},{"issue":"3","key":"10.1016\/j.lanwpc.2024.101032_bib2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.lanwpc.2024.101032_bib3","first-page":"246","article-title":"Interpret the definition and classification of dry eye in the 2017 dry eye expert consensus of the international tear film and ocular surface association","volume":"54","author":"Liu","year":"2018","journal-title":"Chin J Ophthalmol"},{"issue":"6","key":"10.1016\/j.lanwpc.2024.101032_bib4","first-page":"473","article-title":"Expert consensus on the standardization of dry eye diagnosis and treatment centres in China (2021)","volume":"39","year":"2021","journal-title":"Chin J Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.lanwpc.2024.101032_bib5","first-page":"73","article-title":"Expert consensus on clinical diagnosis and treatment of dry eye (2013)","volume":"49","year":"2013","journal-title":"Chin J Ophthalmol"},{"issue":"1","key":"10.1016\/j.lanwpc.2024.101032_bib6","first-page":"46","article-title":"Advances on the epidemiology of the dry eye Chinese Journal of Ophthalmology (electronic version)","volume":"10","author":"Wei","year":"2020"},{"issue":"12","key":"10.1016\/j.lanwpc.2024.101032_bib7","first-page":"907","volume":"56","year":"2020","journal-title":"Chin J Ophthalmol"},{"issue":"3","key":"10.1016\/j.lanwpc.2024.101032_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.lanwpc.2024.101032_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/ICL.0000000000000643","article-title":"A\u00a0new perspective on dry eye classification: proposal by the Asia dry eye society","volume":"46 Suppl 1","author":"Tsubota","year":"2020","journal-title":"Eye Contact Lens"},{"issue":"2","key":"10.1016\/j.lanwpc.2024.101032_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1124\/jpet.112.194852","article-title":"Varenicline is a potent partial agonist at \u03b16\u03b22\u2217 nicotinic acetylcholine receptors in rat and monkey striatum","volume":"342","author":"Bordia","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.lanwpc.2024.101032_bib11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/mol.106.025130","article-title":"Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha 7 neuronal nicotinic receptors","volume":"70","author":"Mihalak","year":"2006","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.lanwpc.2024.101032_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.preteyeres.2009.04.003","article-title":"Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases","volume":"28","author":"Dartt","year":"2009","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.lanwpc.2024.101032_bib13","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.2147\/OPTH.S284622","article-title":"Stimulating tear production: spotlight on neurostimulation","volume":"15","author":"Yu","year":"2021","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.lanwpc.2024.101032_bib14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00003226-199711000-00008","article-title":"Nasolacrimal stimulation of aqueous tear production","volume":"16","author":"Gupta","year":"1997","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.lanwpc.2024.101032_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/chemse\/25.1.61","article-title":"Evidence for nicotinic acetylcholine receptors on nasal trigeminal nerve endings of the rat","volume":"25","author":"Alimohammadi","year":"2000","journal-title":"Chem Senses"},{"issue":"3","key":"10.1016\/j.lanwpc.2024.101032_bib16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/hbm.20535","article-title":"Activation of olfactory and trigeminal cortical areas following stimulation of the nasal mucosa with low concentrations of S(-)-nicotine vapor--an fMRI study on chemosensory perception","volume":"30","author":"Albrecht","year":"2009","journal-title":"Hum Brain Mapp"},{"issue":"4","key":"10.1016\/j.lanwpc.2024.101032_bib17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ophtha.2021.11.004","article-title":"Efficacy and safety of OC-01 (Varenicline Solution) nasal spray on signs and symptoms of dry eye disease: the ONSET-2 phase 3 randomized trial","volume":"129","author":"Wirta","year":"2022","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.lanwpc.2024.101032_bib18","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/ICO.0000000000002941","article-title":"ONSET-1 phase 2b randomized trial to evaluate the safety and efficacy of OC-01 (Varenicline Solution) nasal spray on signs and symptoms of dry eye disease","volume":"41","author":"Wirta","year":"2022","journal-title":"Cornea"},{"key":"10.1016\/j.lanwpc.2024.101032_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jtos.2021.12.007","article-title":"A\u00a0phase II randomized trial to evaluate the long-term (12-week) efficacy and safety of OC-01 (Varenicline Solution) nasal spray for dry eye disease: the MYSTIC study","volume":"24","author":"Quiroz-Mercado","year":"2022","journal-title":"Ocul Surf"},{"key":"10.1016\/j.lanwpc.2024.101032_bib20","series-title":"Dry eye: developing drugs for treatment guidance for industry: draft guidance","year":"2020"},{"issue":"6","key":"10.1016\/j.lanwpc.2024.101032_bib22","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.3390\/ijms24065597","article-title":"The SARS-CoV-2 virus and the cholinergic system: spike protein interaction with human nicotinic acetylcholine receptors and the nicotinic agonist varenicline","volume":"24","author":"Carlson","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.lanwpc.2024.101032_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00210-022-02346-9","article-title":"Cholinergic dysfunction in COVID-19: frantic search and hoping for the best","volume":"396","author":"Nadwa","year":"2023","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"7","key":"10.1016\/j.lanwpc.2024.101032_bib24","first-page":"1096","article-title":"Corneal staining after instillation of topical anesthetic (SSII)","volume":"29","author":"Josephson","year":"1988","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.lanwpc.2024.101032_bib25","series-title":"Nasal physiology and pathophysiology of nasal disorders","first-page":"1","author":"\u00d6nerci","year":"2013"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606524000269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606524000269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T21:03:22Z","timestamp":1714683802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606524000269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":24,"alternative-id":["S2666606524000269"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101032","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Varenicline solution nasal spray for dry eye disease in Chinese patients: a randomized phase 3 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101032"}}